CFIGY (Challenger) ROCE %: 5.23% (As of Dec. 2025)


CFIGY Challenger Ltd CFIGY
59 GF Score
Price $43.70
GF Value $18.80
! 8 Warning Signs
View Full Analysis

What is Challenger ROCE %?

Challenger CFIGY 59 ROCE % is 5.23% as of Dec. 2025. GuruFocus rates CFIGY with a GF Score™ of 59/100 and a GF Value™ of $18.80. The stock has 8 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Challenger's annualized ROCE % for the quarter that ended in Dec. 2025 was 5.23%.

Challenger  (OTCPK:CFIGY) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Challenger ROCE % Related Terms

Challenger ROCE % Historical Data

* Premium members only.

The historical data trend for Challenger's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Challenger ROCE % Chart

Challenger Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.40 1.60 3.72 3.64 4.04

Challenger Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.61 3.82 4.27 4.06 5.23
CFIGY
59GF Score
Challenger Ltd CFIGY
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Challenger ROCE % Calculation

Challenger's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=714.844/( ( (22182.537 - 4485.126) + (22756.576 - 5071.419) )/ 2 )
=714.844/( (17697.411+17685.157)/ 2 )
=714.844/17691.284
=4.04 %

Challenger's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=952.16/( ( (22756.576 - 5071.419) + (23495.681 - 4768.305) )/ 2 )
=952.16/( ( 17685.157 + 18727.376 )/ 2 )
=952.16/18206.2665
=5.23 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 5.23% mean?
Challenger (CFIGY) has a ROCE % of 5.23% as of Dec. 2025.
Is Challenger's ROCE % too high?
Challenger's current ROCE % is 5.23%. The Insurance industry median ROCE % is 8.53. Challenger's value of 5.23% is 38.7% below this industry median. Overall, Challenger has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Challenger's ROCE % compare to AFL and MET?
Challenger's ROCE % of 5.23% can be compared against companies in the Insurance industry. The industry median ROCE % is 8.53. Challenger's value of 5.23% is 38.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for an Insurance company?
The median ROCE % among Insurance companies is 8.53, based on 63 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Challenger's current ROCE % of 5.23% is 38.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Insurance industry, the median ROCE % is 8.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Challenger's current ROCE % is 5.23%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Challenger stock overvalued right now?
Challenger (CFIGY) has a current ROCE % of 5.23%. The stock's GF Value™ is $18.80, compared to a current price of $43.70 — trading 132.4% above its estimated fair value. The current ROCE % is 5.23% and 38.7% below the Insurance industry median of 8.53. Challenger's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Challenger (CFIGY), the current ROCE % is 5.23% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Challenger (CFIGY) Overvalued in 2026?

Based on GuruFocus' analysis, Challenger stock appears to be overvalued. The current stock price of $43.70 is trading 132.4% above its estimated GF Value™ of $18.80.

Key valuation signals for CFIGY:

  • ROCE %: 5.23%
  • GF Value™: $18.80 vs. price of $43.70 (132.4% above fair value)
  • GF Score™: 59/100 with 8 warning signs
  • Industry Position: 38.7% below the Insurance median

No single metric tells the full story. See the CFIGY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Challenger Business Description

Address 5 Martin Place, Level 2, Sydney, NSW, AUS, 2000
Challenger's core business is selling annuity products in the Australian retirement market and, since November 2016, selling Australian dollar-denominated annuities into Japan's large retirement market. The firm's annuity products provide investors guaranteed regular payments over an agreed term for an upfront lump sum investment and is designed primarily to protect investors from the longevity risk of outliving their savings. Challenger also operates a funds management business, Fidante Partners, which has minority stakes in several boutique global investment managers, and Challenger Investment Management, which primarily manages investments supporting its annuities business.
59GF Score

Get the complete analysis for CFIGY

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$43.70
Price
$18.80
GF Value